Intel's massive earnings beat proves the AI hardware boom is expanding beyond the usual market leaders. With their sales growing at the fastest rate in 15 years and the stock already up 170% this year, this positive shift in the business makes the stock a

Verdict: Pass — real revenue, broken fundamentals, no edge in the rules

Intel's 36.1% revenue growth is genuine and lands in the 65th percentile among IT peers, but the company posted a GAAP net loss of $267 million with free cash flow at negative $4.9 billion — the 0th percentile across 580 peers — making this a turnaround priced as a momentum story. The 60-month backtest headline of a 55.2% win rate and 5.5% max drawdown looks reasonable, but the recent 24-month window tells the real story: 226 trades, a 38.1% win rate, negative 8.8% cumulative return, and a 21.8% peak-to-trough drawdown that is catastrophic for a strategy running 2.5% stops. No robust parameter setup was established; all four walk-forward variants were rejected after failing to produce a positive return in the final 12-month holdout, with the baseline itself returning negative 1.2%. The entry conditions are not yet armed — the 9-period EMA sits $4.94 below the 21-period EMA and RSI is 0.8 points shy of 40 — so this is a wait, not a trade, and even if it triggers, the recent evidence does not support taking it. With operating margin at negative 4.2% and capex of $14.6 billion against operating cash flow of $9.7 billion, Intel is buying growth at a cash cost the strategy's tight risk controls are not designed to absorb. **Conviction breakdown:** - **Thesis support (35/100):** Revenue growth is real but profitability is absent; free cash flow is the worst in the peer set. - **Trade readiness (20/100):** Two of three entry conditions are unmet; the EMA crossover is far from triggering. - **Risk quality (30/100):** A 21.8% recent drawdown against 2.5% stops signals repeated stop-outs and poor risk-adjusted behavior. - **Backtest evidence (25/100):** The 24-month window with a 38.1% win rate and negative 8.8% return overwhelms the flattering 60-month numbers; no parameter variant passed holdout. - **Fundamentals trend (40/100):** Top-line acceleration is undermined by negative margins, negative returns on equity and assets, and accelerating cash burn.

Trade now

Intel closed the last session at $91.67, and the strategy's entry requires three conditions to align simultaneously. The ADX (14) is at 52.4, well above the 20 threshold — that condition is met and signals strong directional momentum. However, the 9-period EMA ($92.37) has not yet crossed above the 21-period EMA ($97.30); it sits $4.94 below, placing this condition in the far zone. RSI (14) is at 39.2, just 0.8 below the required 40 threshold, making it the nearest unresolved trigger. Until both the RSI pushes above 40 and the short EMA reclaims the long EMA, the setup is not armed. "Wait" here means monitoring the daily chart for a close where RSI finishes above 40 and the 9-period EMA crosses back above the 21-period EMA on the same bar or within a tight sequence. The thesis — built on Intel's AI-driven revenue acceleration and the stock's 170% year-to-date run — is fundamentally bullish, but the mechanical rules demand a momentum confirmation that has not yet arrived. On the exit side, the strategy enforces a hard stop loss at 2.5% and a take-profit target at 5.0%, yielding an effective reward-to-risk ratio of roughly 2:1. In price terms from $91.67, that translates to a downside invalidation near $89.38 and an upside target near $96.26. The strategy also carries structural exits: a close below support level 2 ($89.79) or an RSI push above 75 would trigger an early exit. Over the 60-month backtest window, the strategy produced 29 trades with a 55.2% win rate and a 1.1% return, though the more recent 24-month window was less favorable, returning -8.8% across 226 trades with a 38.1% win rate. No robust parameter setup was established through bounded walk-forward optimization; the final 12-month holdout returned -1.24% with a 40.0% win rate across 15 trades, and all four tested variants (EMA periods 7 and 11, RSI thresholds 36 and 44) were rejected for non-positive holdout returns. Treat the frozen baseline configuration as the…

Scores

• Conviction score breakdown: 30
• Thesis support: 35
• Trade readiness: 20
• Risk quality: 30
• Backtest evidence: 25
• Fundamentals trend: 40

Watch items

• INTC — RSI (14)
• INTC — 9-period EMA vs 21-period EMA
• INTC — ADX (14)
• INTC — Support level 1
• INTC — RSI (14) — overbought exit
• INTC — EMA (9) crossed above EMA (21)
• INTC — RSI (14) above 40
• INTC — ADX (14) above 20
• INTC — RSI (14) above 75
• INTC — EMA (9) crossed below EMA (21)